Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lipitor Study May Influence Stroke Clinical Guidelines – NEJM Editorial

Executive Summary

Results of a study showing that Pfizer's Lipitor reduced the overall incidence of stroke in patients with a recent stroke or transient ischemic attack is likely to encourage the adoption of statin therapy into stroke treatment guidelines, according to an editorial by David Kent (Tufts-New England Medical Center) in the Aug. 10 New England Journal of Medicine
Advertisement

Related Content

Cholesterol Playing Field Expands To Early Atherosclerosis, HDL, Novel Drugs
Cholesterol Playing Field Expands To Early Atherosclerosis, HDL, Novel Drugs
Advertisement
UsernamePublicRestriction

Register

PS047496

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel